Medtronic Net Profit Margin 2010-2025 | MDT
Current and historical net profit margin for Medtronic (MDT) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Medtronic net profit margin for the three months ending January 31, 2025 was .
| Medtronic Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-01-31 | $33.20B | $4.26B | 12.83% |
| 2024-10-31 | $33.00B | $4.29B | 13.00% |
| 2024-07-31 | $32.58B | $3.93B | 12.05% |
| 2024-04-30 | $32.36B | $3.68B | 11.36% |
| 2024-01-31 | $32.32B | $4.20B | 13.00% |
| 2023-10-31 | $31.96B | $4.10B | 12.84% |
| 2023-07-31 | $31.56B | $3.62B | 11.47% |
| 2023-04-30 | $31.23B | $3.76B | 12.03% |
| 2023-01-31 | $30.77B | $4.06B | 13.20% |
| 2022-10-31 | $30.81B | $4.32B | 14.03% |
| 2022-07-31 | $31.07B | $5.21B | 16.75% |
| 2022-04-30 | $31.69B | $5.04B | 15.90% |
| 2022-01-31 | $31.79B | $4.91B | 15.46% |
| 2021-10-31 | $31.80B | $4.70B | 14.79% |
| 2021-07-31 | $31.60B | $3.88B | 12.29% |
| 2021-04-30 | $30.12B | $3.61B | 11.97% |
| 2021-01-31 | $27.93B | $2.89B | 10.36% |
| 2020-10-31 | $27.87B | $3.54B | 12.69% |
| 2020-07-31 | $27.93B | $4.41B | 15.80% |
| 2020-04-30 | $28.91B | $4.79B | 16.56% |
| 2020-01-31 | $31.06B | $5.32B | 17.11% |
| 2019-10-31 | $30.89B | $4.67B | 15.11% |
| 2019-07-31 | $30.67B | $4.42B | 14.41% |
| 2019-04-30 | $30.56B | $4.63B | 15.16% |
| 2019-01-31 | $30.56B | $4.92B | 16.10% |
| 2018-10-31 | $30.38B | $2.26B | 7.44% |
| 2018-07-31 | $29.95B | $3.16B | 10.56% |
| 2018-04-30 | $29.95B | $3.10B | 10.36% |
| 2018-01-31 | $29.73B | $2.81B | 9.44% |
| 2017-10-31 | $29.64B | $5.02B | 16.93% |
| 2017-07-31 | $29.93B | $4.12B | 13.75% |
| 2017-04-30 | $29.71B | $4.03B | 13.56% |
| 2017-01-31 | $29.36B | $3.97B | 13.51% |
| 2016-10-31 | $29.01B | $4.24B | 14.62% |
| 2016-07-31 | $28.73B | $3.65B | 12.70% |
| 2016-04-30 | $28.83B | $3.54B | 12.27% |
| 2016-01-31 | $28.57B | $2.43B | 8.52% |
| 2015-10-31 | $25.95B | $2.32B | 8.92% |
| 2015-07-31 | $23.26B | $2.62B | 11.28% |
| 2015-04-30 | $20.26B | $2.68B | 13.20% |
| 2015-01-31 | $17.52B | $3.12B | 17.83% |
| 2014-10-31 | $17.37B | $2.91B | 16.75% |
| 2014-07-31 | $17.20B | $2.98B | 17.35% |
| 2014-04-30 | $17.01B | $3.07B | 18.02% |
| 2014-01-31 | $16.90B | $3.59B | 21.22% |
| 2013-10-31 | $16.76B | $3.81B | 22.74% |
| 2013-07-31 | $16.67B | $3.56B | 21.34% |
| 2013-04-30 | $16.59B | $3.47B | 20.90% |
| 2013-01-31 | $16.43B | $3.49B | 21.23% |
| 2012-10-31 | $16.32B | $3.44B | 21.05% |
| 2012-07-31 | $16.25B | $3.66B | 22.53% |
| 2012-04-30 | $16.18B | $3.62B | 22.35% |
| 2012-01-31 | $15.86B | $3.40B | 21.45% |
| 2011-10-31 | $15.80B | $3.39B | 21.47% |
| 2011-07-31 | $15.68B | $3.09B | 19.69% |
| 2011-04-30 | $15.51B | $3.10B | 19.96% |
| 2011-01-31 | $15.30B | $3.28B | 21.40% |
| 2010-10-31 | $15.30B | $3.18B | 20.80% |
| 2010-07-31 | $15.23B | $3.48B | 22.87% |
| 2010-04-30 | $15.39B | $3.10B | 20.13% |
| 2010-01-31 | $15.45B | $2.25B | 14.54% |
| 2009-10-31 | $15.09B | $2.11B | 14.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $112.764B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.977B | 28.52 |
| Boston Scientific (BSX) | United States | $155.488B | 41.98 |
| Stryker (SYK) | United States | $147.446B | 31.70 |
| EssilorLuxottica (ESLOY) | France | $140.780B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.084B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.818B | 29.12 |
| GE HealthCare Technologies (GEHC) | United States | $42.113B | 20.51 |
| Agilent Technologies (A) | United States | $39.025B | 25.86 |
| ResMed (RMD) | United States | $34.189B | 26.33 |
| Terumo (TRUMY) | Japan | $26.310B | 37.41 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 16.80 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.630B | 12.95 |
| Insulet (PODD) | United States | $20.222B | 86.57 |
| Baxter (BAX) | United States | $17.074B | 12.34 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.245B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.513B | 35.65 |
| Bio-Rad Laboratories (BIO) | United States | $8.001B | 27.70 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 13.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.200B | 20.05 |
| ICU Medical (ICUI) | United States | $3.995B | 38.03 |
| Envista Holdings (NVST) | United States | $3.693B | 29.38 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.188B | 15.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.921B | 19.69 |
| QuidelOrtho (QDEL) | United States | $2.760B | 23.18 |
| LeMaitre Vascular (LMAT) | United States | $2.269B | 55.15 |
| Neogen (NEOG) | United States | $2.178B | 25.10 |
| AtriCure (ATRC) | United States | $1.914B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.484B | 25.90 |
| InMode (INMD) | Israel | $1.320B | 11.03 |
| BioLife Solutions (BLFS) | United States | $1.276B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.180B | 8.43 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.997B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.938B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.930B | 14.27 |
| Evolus (EOLS) | United States | $0.926B | 0.00 |
| CeriBell (CBLL) | United States | $0.828B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.689B | 0.00 |
| Valneva SE (VALN) | France | $0.643B | 0.00 |
| Omeros (OMER) | United States | $0.557B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.529B | 22.95 |
| Owens & Minor (OMI) | United States | $0.494B | 3.86 |
| Surmodics (SRDX) | United States | $0.492B | 0.00 |
| SNDL (SNDL) | Canada | $0.462B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.321B | 58.60 |
| Viemed Healthcare (VMD) | United States | $0.310B | 29.52 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Biote (BTMD) | United States | $0.260B | 5.69 |
| Canopy Growth (CGC) | Canada | $0.250B | 0.00 |
| Zynex (ZYXI) | United States | $0.236B | 49.40 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| Brainsway (BWAY) | Israel | $0.212B | 112.80 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.206B | 15.39 |
| MacroGenics (MGNX) | United States | $0.181B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.112B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 12.79 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| InterCure (INCR) | Israel | $0.075B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Exagen (XGN) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.058B | 30.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| MariMed (MRMD) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.22 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| INLIF (INLF) | $0.040B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |